Molecular proximity for targeted treatments: PROTACs and other bifunctional molecules. Session organised by CQDM

The future of bifunctional molecules as a therapeutic modality is promising. These molecules are designed to induce proximity and interactions between two specific therapeutic targets of interest. Depending on the proteins targeted, this induced proximity can lead to many different therapeutic approaches, including targeted protein degradation, activation of specific proteins or the targeting of a particular cell type. Their ability to create specific and synergistic interactions between their targets paves the way for more effective personalized therapies to combat a variety of diseases, including cancer, inflammatory diseases and neurological disorders. Bifunctional molecules have the potential to revolutionize the medical landscape, and as such, could play a key role in improving healthcare in the future.

Facilitator

Véronique Dugas, PhD, MBA 
Vice-president, Scientific affairs, CQDM

Speakers

Cameron Black, PhD
EVP Discovery, Repare Therapeutic

Anthony Rullo, PhD
Associate Professor, Department of Medicine, McMaster University 

Daniel Simard, 
Research Investigator, Sanofi

Jamal Daoud, PhD M.E.Sc.
Founder and Executive Director of Galenvs Sciences